Cannabinoid abuse and addiction: Clinical and preclinical findings-Reference-Cited by-同舟云学术

Cannabinoid abuse and addiction: Clinical and preclinical findings

Published:2015-05-02 Issue:6 Volume:97 Page:616-627
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Panlilio LV¹,Goldberg SR¹,Justinova Z¹

Affiliation:

1. Preclinical Pharmacology Section, Behavioral Neuroscience Research Branch, Intramural Research Program, National Institute on Drug Abuse, NIH, DHHS; Baltimore Maryland USA

Funder

National Institute on Drug Abuse, Intramural Research Program, NIH, DHHS

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cpt.118/fullpdf

Reference75 articles.

1. A survey study to characterize use of spice products (synthetic cannabinoids);Vandrey;Drug Alcohol Depend,2012

2. Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order;Drug Enforcement Administration, Department of Justice;Fed. Regist,2014

3. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb;Izzo;Trends Pharmacol. Sci.,2009

4. Does cannabidiol protect against adverse psychological effects of THC?;Niesink;Front. Psychiatry,2013

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Exploration of Cannabis and Cannabinoid Therapies for Migraine;Current Pain and Headache Reports;2023-07-29

2. Cannabis Unveiled: An Exploration of Marijuana’s History, Active Compounds, Effects, Benefits, and Risks on Human Health;Substance Abuse: Research and Treatment;2023-01

3. Mepirapim, a novel synthetic cannabinoid, induces Parkinson’s disease-related behaviors by causing maladaptation of the dopamine system in the brain;Archives of Toxicology;2022-11-10

4. Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review;Health Psychology Research;2022-10-04

5. Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents;Pharmaceuticals;2022-06-03